13F-HR filed by Soleus Capital Management, L.P.
Soleus Capital Management, L.P. filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 76 holding rows worth $735,963,000.
- Accession
- 0001802630-22-000009
- Filer
- CIK 1802630
- Filed
- 2022-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 76 entries on the cover page, a total value of $735,963,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $735,966,000 with VALUE read as thousands by filing date, 13F file number 028-20043. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 234,859 | $49,175,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 2,502,601 | $44,897,000 | thousands by filing date | |
| EDAP TMS S A | 268311107 | SPONSORED ADR | 4,889,745 | $40,340,000 | thousands by filing date | |
| SKINHEALTH SYSTEMS INC | 88331L108 | COM CL A | 2,665,876 | $31,431,000 | thousands by filing date | |
| ILLUMINA INC | 452327109 | COM | 151,600 | $28,924,000 | thousands by filing date | |
| CVS Health Corporation | 126650100 | COM | 285,900 | $27,266,000 | thousands by filing date | |
| BIOATLA INC | 09077B104 | COM | 3,400,503 | $26,184,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 80,800 | $26,127,000 | thousands by filing date | |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 129,100 | $25,407,000 | thousands by filing date | |
| Surmodics Inc | 868873100 | Common Stock | 768,478 | $23,362,000 | thousands by filing date | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 1,239,913 | $23,273,000 | thousands by filing date | |
| ORGANOGENESIS HOLDINGS INC | 68621F102 | COMMON STOCK | 6,489,063 | $21,025,000 | thousands by filing date | |
| IRADIMED CORP | 46266A109 | COMMON STOCK | 684,690 | $20,582,000 | thousands by filing date | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 415,200 | $19,867,000 | thousands by filing date | |
| THERATECHNOLOGIES INC COM | 88338H100 | COM | 8,007,714 | $18,978,000 | thousands by filing date | |
| ENVISTA HOLDINGS CORPORATION | 29415F104 | COM | 480,000 | $15,749,000 | thousands by filing date | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 207,332 | $14,451,000 | thousands by filing date | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 1,441,513 | $12,642,000 | thousands by filing date | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 429,336 | $12,086,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 275,673 | $12,080,000 | thousands by filing date | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 67,400 | $11,955,000 | thousands by filing date | |
| CUTERA INC | 232109108 | COM | 255,792 | $11,664,000 | thousands by filing date | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 535,358 | $10,857,000 | thousands by filing date | |
| CVRX INC | 126638105 | COMMON STOCK | 1,059,040 | $9,881,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 1,025,200 | $9,821,000 | thousands by filing date | |
| NEUROPACE INC | 641288105 | COMMON STOCK | 2,334,003 | $8,753,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 374,000 | $8,677,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 335,650 | $8,056,000 | thousands by filing date | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 297,840 | $7,768,000 | thousands by filing date | |
| INARI MED INC | 45332Y109 | COM | 101,608 | $7,381,000 | thousands by filing date | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 175,300 | $7,317,000 | thousands by filing date | |
| HUMANA INC COM | 444859102 | Stock | 14,200 | $6,890,000 | thousands by filing date | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 504,144 | $6,569,000 | thousands by filing date | |
| INHIBRX INC | 45720L107 | COM | 363,902 | $6,532,000 | thousands by filing date | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 34,800 | $6,523,000 | thousands by filing date | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 123,014 | $6,381,000 | thousands by filing date | |
| APOLLO ENDOSURGERY INC | 03767D108 | COM | 1,137,105 | $6,265,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 23,200 | $6,194,000 | thousands by filing date | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 146,000 | $5,493,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 27,000 | $5,404,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 5,587,789 | $5,308,000 | thousands by filing date | |
| AXOGEN INC | 05463X106 | COM | 424,998 | $5,066,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 2,640,539 | $4,806,000 | thousands by filing date | |
| PIERIS PHARMACEUTICALS INC | 720795103 | COM | 4,134,868 | $4,755,000 | thousands by filing date | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 144,800 | $4,705,000 | thousands by filing date | |
| ENOVIS CORPORATION | 194014502 | COM | 102,100 | $4,704,000 | thousands by filing date | |
| CELCUITY INC | 15102K100 | COM | 443,912 | $4,457,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 96,800 | $3,494,000 | thousands by filing date | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 62,620 | $3,420,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 72,000 | $3,355,000 | thousands by filing date | |
| IMAGO BIOSCIENCES INC | 45250K107 | COM | 213,000 | $3,206,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 234,026 | $3,045,000 | thousands by filing date | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 592,417 | $2,968,000 | thousands by filing date | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 135,618 | $2,849,000 | thousands by filing date | |
| ORASURE TECHNOLOGIES INC | 68554V108 | COM | 565,000 | $2,141,000 | thousands by filing date | |
| INMODE LTD SHS | M5425M103 | Stock | 67,449 | $1,963,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 23,836 | $1,920,000 | thousands by filing date | |
| 89BIO INC | 282559103 | COM | 330,000 | $1,911,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 219,000 | $1,649,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 64,027 | $1,633,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 78,000 | $1,533,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 67,300 | $1,508,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 22,000 | $1,438,000 | thousands by filing date | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 14,100 | $1,405,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 1,644,500 | $1,398,000 | thousands by filing date | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 453,660 | $1,320,000 | thousands by filing date | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 87,182 | $1,257,000 | thousands by filing date | |
| PEPGEN INC COM | 713317105 | Stock | 130,000 | $1,180,000 | thousands by filing date | |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 1,950,000 | $1,157,000 | thousands by filing date | principal |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 13,400 | $915,000 | thousands by filing date | |
| IO BIOTECH INC | 449778109 | COM | 288,119 | $781,000 | thousands by filing date | |
| IMMUNIC INC | 4525EP101 | COM | 240,000 | $758,000 | thousands by filing date | |
| DA32 LIFE SCNCE TEC ACQSTN C | 23312M106 | CLASS A COM | 50,000 | $487,000 | thousands by filing date | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 21,200 | $443,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 25,300 | $404,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 19,518 | $400,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001802630-22-000009 | this filing | 2022-11-14 | acceptance time not in the bulk data set |